Home › Blood Cancers › NCT06472089
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Caregiver Inclusion Criteria: * Adult caregivers (≥18 years) relative or friend of a patient identified as living with them or having in-person contact with them at least twice a week. * Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer. * Ability to read and respond to survey questions in English, Spanish or with minimal assistance from an interpreter. Caregiver Exclusion Criteria: * Caregivers of patients undergoing HCT for a benign hematologic condition or undergoing outpatient HCT. * Caregivers with a major untreated psychiatric or cognitive condition which the treating oncology clinicians believes interferes with the capacity to provide informed consent. * Caregivers of patients who have already undergone HCT within the past 5 years Patient Inclusion Criteria: * Adult patients (≥18 years) with a hematologic malignancy and planned admission for autologous or allogeneic HCT. * Ability to respond to questions in English, Spanish, or with minimal assistance from an interpreter.
About the study
The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.
What is being tested
- BMT-CARE (behavioral)
- Usual Care (behavioral)
Sponsor: Massachusetts General Hospital · Participants: 800 · Started: Jan 10, 2025
Contact the study team
- Areej El-Jawahri, MD · Phone: 617-721-4000
- Jamie Jacobs, PhD · Phone: 617-724-4000
Official record on ClinicalTrials.gov — NCT06472089
Locations in the U.S.
| Alabama | University of Alabama at Brimingham, Birmingham |
| Florida | Moffitt Cancer Center, Tampa |
| Massachusetts | Massachusetts General Hospital Cancer Center, Boston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.